The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy

Annals of the New York Academy of Sciences

Volumn 920, Issue , 2000, Pages 16-27

  Spillantini, Maria Grazia ^a,b   Goedert, Michel ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; RECOMBINANT PROTEIN;

ALZHEIMER DISEASE; CELL INCLUSION; CELL STRUCTURE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; HUMAN; LEWY BODY; MISSENSE MUTATION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; SHY DRAGER SYNDROME;

EID: 0034531475     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06900.x     Document Type: Conference Paper

References (82)

1. Paralysis agitans. I. Pathologische Anatomie
2. Neuropathology of Parkinson's disease
3. Phase and electron microscopic observations on Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease
4. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion
5. Lewy bodies in cerebral cortex. Report of three cases
6. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity
7. Senile dementia of the Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
8. Mutation in the α-synuclein gene identified in families with Parkinson's disease
9. α-Synuclein in Lewy bodies
10. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
11. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
12. Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
13. Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia
14. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
15. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein
16. Widespread occurrence of α-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies
17. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
18. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
19. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
20. Multiple system atrophy: A new α-synuclein disease?
21. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
22. The rat brain synucleins; family of proteins transiently associated with neuronal membrane
23. Cloning and characterization of the cDNA encoding a novel specific 14-kDa protein
24. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
25. α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid cores
26. Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited. NAC and α-synuclein are not associated with Aβ amyloid
27. Identification of two distinct synucleins from human brain
28. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
29. The NACP/α-synuclein gene: Chromosomal assignment and screening for alterations in Alzheimer disease
30. The human NACP/α-synuclein gene: Chromosome assignment to 4q21-.3-q22 and Taql RFLP analysis
31. Assignment of human α-synuclein (SNCA) and •-synuclein (SNCB) genes to chromosomes 4q21 and 5q35
32. High-resolution mapping of SNCA encoding α-synuclein, the non-Aβ component of Alzheimer's disease precursor, to human chromosome 4q21.3-q22 by fluorescence in situ hybridization
33. Genomic organization and expression of the human β-synuclein gene (SNCB)
34. Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-Aβ component of Alzheimer's disease amyloid
35. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
36. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes
37. Binding of α-synuclein to rat brain vesicles is abolished by familial Parkinson's disease mutation
38. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins
39. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization
40. Constitutive phosphorylation of the Parkinson's disease-associated α-synuclein
41. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing
42. Alpha-synuclein and the Lewy body
43. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system
44. Identification, localization and characterization of the human γ-synuclein gene
45. Organization, expression and polymorphism of the human persyn gene
46. Synoretin - A new protein belonging to the synuclein family
47. A large kindred with autosomal dominant Parkinson's disease
48. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
49. Genetic analysis of families with Parkinson disease that carry the Ala53thr mutation in the gene encoding α-synuclein
50. No pathogenic mutations in the persyn gene in Parkinson's disease
51. No pathogenic mutations in the β-synuclein gene in Parkinson's disease
52. Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease
53. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
54. Degradation of α-synuclein by proteasome
55. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
56. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders
57. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
58. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
59. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease
60. Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein
61. Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by α-synuclein immunocytochemistry
62. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein
63. A panel of epitope-specific antibodies detects protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson's disease
64. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
65. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
66. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy
67. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy
68. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies
69. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
70. α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain reveals multiprotein components
71. Widespread alterations of α-synuclein in multiple system atrophy
72. No mutation in the entire coding region of the α-synuclein gene in pathologically confirmed cases of multiple system atrophy
73. Synthetic filaments assembled from C-terminally truncated α-synuclein
74. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease
75. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
76. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro
77. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation
78. α-Synuclein fibrillogenesis is nucleation-dependent
79. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
80. The core of Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease?